While research is still developing, early evidence suggests that microbiome health may impact incretin medication effectiveness
Many patients taking Ozempic have type 2 diabetes, a condition independently associated with peripheral neuropathy, peripheral arterial disease, and increased risk of foot complications
Pola, P., Tondi, P., Flore, R., Serricchio, M., Dal Lago, A., Amanti, C., Consorti, F., Benedetti, M., and Midiri, H
To improve chances of coverage: Ensure proper documentation of medical necessity Complete required prior authorizations Meet specific plan criteria Work with healthcare providers for proper coding Several options may exist for accessing Ozempic at reduced or no cost: Novo Nordisk Patient Assistance Program: Available to eligible U.S
Teladoc Health expands obesity and weight management capabilities